Thanks, Jack.
Let's to go Slide X.
comparable our our shipment several be of XXXX long-cycle portfolio our that counter performance offset with intended half in First second in and curtail toughest operating cyclicality expectations. the our clear biopharma Strong end to of together we what year. and to order effect. quarter took posture platforms, to of results trends was our is that improving in growth the some It has with components quarter across in its had able markets production were we're expected proactively this line
inventories and channel now level and times. are with conditions balance Customer set largely lead prevailing demand in to normalize
was an full broad-based, particularly remain and confidence end off We on the in strong bolstering building from exit rate deployment. As active quarter a last in outlook. order result, shorter-cycle markets, year year momentum capital our our and
The of ongoing part March streams reoccurring end the and add closed divestiture attractive During fueling closed portfolio acquisitions as and De-Sta-Co bolt-on at platforms. retail our we that our the quarter, carwash to evolution. of revenue X synergistic of digital
at of shareholders. the We a to program excess capital share our $XXX million February to return end also repurchase launched accelerated
with capital the the in XXXX. generation flow De-Sta-Co further for proceeds deployment provide ample Our capacity strong of cash along sale
the to the start a the to year We're off for remainder of encouraging. and is year setup solid the
support rate the through order Our conditions margin and volume the demand as progress for improvement outlook year. underlying momentum and healthy we
full full progresses towards the range, our as EPS We higher year the are evaluate and adjusted end if the targets continue we'll demand to trends year narrowing our of especially continue. guidance year
quarters to after Of we go in Revenue in growing Slide a the in the Bookings decline, growth post-COVID of X up the positive much this X% positive rest sequentially the organically trend X. up note, continue to of quarter. bookings X as and year-over-year Let's result X% order up straight bookings was across the rate quarters the XX% now expect portfolio. reflecting seen backlogs, of have quarter, year. momentum were of and for
Segment margins were down basis points. XX.X%, XX
volume up We on guiding to and expect year positive here leverage. to to mix quarter, to from X% accretion share Adjusted growth per XXXX. return revenue EPS was for the $X adjusted we $X.XX EPS in are X% and of organic the $X.XX year-over-year to and
better Europe. trajectory defense bookings and revenue in Aerospace double-digit and growth. on order strong and posted aftermarket vehicle including in and Volumes handling, waste particularly Engineered So let's for volume set first Products which to a and quarter had robust all-time conversion its move growth. should positive quarter, on X. software body growth, truck also momentum on an Slide improved continue market adoption. end strong conditions profits record
'XX channel the in destocking North heavy our X the steady were quarter fueling here Margins positive returned growth XXXX. the performance most quarter margins we by and on the over most segment. Margin target to full conversion expect expect of Europe America and improvement measures. U.S., to the is the [ by offset flat quarters performance what benefits of volume in the EMV solid and to Energy from dynamics printer a and Identification investments. sequential and year driven strong down quarter posted in and conversion, in strong quarter negative Imaging by volume exposed of consecutive remain segment the and up from in mix, shipments -- We organic after productivity negative lower to distribution with Clean line throughout cost enacted was ] volumes driven previously for largely comparable consumables top see cycle on price/cost but control strong & volumes attractive in end aftermarket.
and to process quarter for consumables We and year. and in on growth next to organically connectors components. higher precision for volumes be shipments. controls mix to Order Margin the and were rates very return encouraging. line up was Thomson on robust thermal was polymer quarter cost expect up performance the aftermarket of processing top exemplary in
are normalize shipments to continue We with grow year-over-year orders remain momentum production further X.XX commercial biopharma with and as see gained pleased of development book-to-bill and new a therapy robust. customer inventories to drug
that Top complex, expected destocking be by in strong plate polymer our in can-making point to exchanger Climate is and and were heat down biopharma headwinds HVAC out which beverage was investment are margins the volumes nearly by as segment Margins post in down destocking segment residential If the here. the in broader expect dilutive impact Sustainability due like driven consumable all heat the in we mostly capital most pandemic processing, to this consolidated modestly volumes, sequentially slightly headwinds on hold, was which is margin. growing. dissipate, biopharma business in notably homes performance would order slowdown our and brazed trends European the to line in production business. trends positive I to Technologies the driven expected, -- from of
evolving continues on digits heat market technology U.S. gains exchanger an grow business our in end share including in centers. contrast, double data applications, to In
in several strong year line build-out COX key top with by of the on segment year supported expect wins. We systems, performance the the in second to drove improve growth half bookings for customer progresses the the which easier and volume comparable refrigeration as
on it I'll pass to Brad.